GlassScriptPhysician profile
Jamie Lynn Temple
NPI 1174159644
$6,583.13
in general payments reported to CMS, 2019-2025
48 companies · $1,088 in 2025
The $1,088 reported for 2025 was more than what 88% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $52.85 · 2022: $2,874 · 2023: $1,985 · 2024: $584 · 2025: $1,088.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,656.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $830.18 | 2022-2025 | Imfinzi, Farxiga, Tagrisso |
| Janssen Pharmaceuticals, INC | $723.80 | 2021-2023 | Xarelto |
| Daiichi Sankyo INC. | $655.44 | 2022-2023 | Injectafer, Enhertu |
| Boehringer Ingelheim Pharmaceuticals, INC. | $354.38 | 2022-2024 | Jardiance |
| Astellas Pharma US INC | $343.13 | 2022-2025 | Vyloy, Padcev, Xospata |
| Novartis Pharmaceuticals Corporation | $331.44 | 2022-2025 | |
| Amgen INC. | $298.74 | 2021-2025 | Imdelltra (Amg757), Kyprolis, Evenity |
| Pfizer INC. | $251.28 | 2022-2025 | |
| Janssen Biotech, INC. | $241.39 | 2022-2023 | Darzalex, Tecvayli, Carvykti |
| E.R. Squibb & Sons, L.L.C. | $220.20 | 2022-2025 | Reblozyl, Pomalyst |
| Eisai INC. | $189.16 | 2022-2023 | |
| Genzyme Corporation | $166.42 | 2022-2023 | |
| Emd Serono, INC. | $157.86 | 2023 | Bavencio |
| Pharmacosmos Therapeutics INC. | $155.81 | 2023-2025 | Cosela, Monoferric |
| Beone Medicines USA, INC. | $135.34 | 2025 | Tevimbra |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Temple listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.